Monitoring anticoagulation of primary haemostasis: Estimation of platelet function in whole blood assays

Hamostaseologie

Volumn 29, Issue 3, 2009, Pages 279-284

  Calatzis, A ^a   Leitner, M ^b   Panzer, Simon ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ADP receptor inhibitors; Antiplatelet therapy; COX inhibition; GPIIb IIIa inhibition; Monitoring primary haemostasis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRUDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ATHEROSCLEROSIS; BLEEDING TIME; BLOOD CLOTTING TIME; BLOOD SAMPLING; CELL ASSAY; DIAGNOSTIC VALUE; DRUG MONITORING; FEASIBILITY STUDY; FLOW CYTOMETRY; FUNCTIONAL ASSESSMENT; HEMOSTASIS; HUMAN; IMPEDANCE; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY;

EID: 68549111033     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617037     Document Type: Review

References (30)

1. Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929.
2. Carville DG, Schleckser PA, Guyer KE et al. Whole blood platelet function assay on the ICHOR pointof- care hematology analyzer. J Extra Corpor Technol 1998; 30: 171-177.
3. Clemetson KJ. Platelet receptors and their role in diseases. Clin Chem Lab Med 2003; 41: 253-260. (Pubitemid 36432828)
4. Craft RM, Chavez JJ, Snider CC et al. Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med 2005; 145: 309-315.
5. Duke WW. The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and the coagulation time and report of three cases of hemorrhagic disease relieved by blood transfusion. JAMA 1910; 55: 1185-1192.
6. Frossard M, Fuchs I, Leitner JM et al. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 2004; 110: 1392-1397. (Pubitemid 39238016)
7. Fuchs I, Frossard M, Spiel A et al. Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS. J Thromb Haemost 2006; 4: 2547-2552. (Pubitemid 44741545)
8. Gremmel T, Steiner S, Seidinger D et al. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation. Thromb Haemost 2009; 101: 333-339.
9. Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972; 287: 155-159.
10. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138: 152-163. (Pubitemid 32812228)
11. Jilma B, Fuchs I. Detecting aspirin resistance with the platelet function analyzer (PFA-100). Am J Cardiol 2001; 88: 1348-1349. (Pubitemid 33132116)
12. Jurk K, Kehrel BE. The role of platelets in haemostasis, thrombosis, immune defense and inflammation. Dtsch Med Wochenschr 2008; 133:1130-1135. (Pubitemid 351829651)
13. Lennon MJ, Gibbs NM, Weightman WM et al. A comparison of Plateletworks and platelet aggregometry for the assessment of aspirin related platelet dysfunction in cardiac surgical patients. J Cardiothorac Vasc Anesth 2004; 18: 136-140.
14. Matetzky S, Shenkman B, Guetta V et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004; 109: 3171-3175.
15. Matetzky S, Fefer P, Shenkman B et al. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction. Am J Cardiol 2008; 102: 524-529.
16. Mielke CH Jr, Kaneshiro MM, Maher IA et al. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34: 204-215.
17. Nilsson IM, Magnusson S, Borchgrevink C. The Duke and Ivy methods for determination of the bleeding time. Thromb Diath Haemorrh 1963; 10: 223-234.
18. Nurden AT, Nurden P, George JN. Are patients with Glanzmann thrombasthenia and the Bernard-Soulier syndrome protected against atherosclerosis? Adv Exp Med Biol 2001; 489: 13-29.
19. O'Brien JM. Platelet aggregation. II. Some results from a new method of study. J Clin Pathol 1962; 15: 452-481.
20. Panzer S, Höcker L, Koren D. Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry. Ann Hematol 2006; 85: 121-125. (Pubitemid 43085307)
21. Panzer S, Rieger M, Vormittag R et al. Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia. Eur J Clin Invest 2007; 37: 814-819. (Pubitemid 47480842)
22. Savion N, Varon D. Impact-the cone and plate(let) analyzer: testing platelet function and anti-platelet drug response. Pathophysiol Haemost Thromb 2006; 35: 83-88. (Pubitemid 44350168)
23. Scharbert G, Kalb ML, Duris M et al. Garlic at dietary doses does not impair platelet function. Anesth Analg 2007; 105: 1214-1218. (Pubitemid 350303918)
24. Shenkman B, Einav Y, Salomon O et al. Testing agonist-induced platelet aggregation by the Impact- R. Platelets 2008; 19: 440-446.
25. Shpilberg O, Rabi I, Schiller K, Walden R et al. Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/ IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis. Circulation 2002; 105: 1044-1048.
26. Sibbing D, Braun S, Morath T et al. Platelet reactivity after clopidogrel treatment assessed with pointof- care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009; 53: 849-856.
27. Siller-Matula JM, Panzer S, Jilma B. Reproducibility and standardized reporting of the vasodilatorstimulated phosphoprotein phosphorylation assay. Platelets 2008; 19: 551-554.
28. Siller-Matula JM, Lang I, Christ G, Jilma B. Calciumchannel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol 2008; 52: 1557-1563.
29. Thromboelastography. Special issue dedicated to Professor Dr. Hellmut Hartert. Semin Thromb Hemost 1995; 21 (Suppl 4): 1-93.
30. White MM, Krishnan R, Kueter TJ et al. The use of the point of care Helena ICHOR/Plateletworks and the Accumetrics Ultegra RPFA for assessment of platelet function with GPIIb-IIIa antagonists. J Thromb Thrombolysis 2004; 18: 163-169. (Pubitemid 40552930)